Lang Matthew
SEC insider (Form 3/4/5 filer). CIK 0001712069. COO & GC at Structure Therapeutics Inc. (GPCR) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on Apr 15, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Lang Matthew has filed insider reports for
- Structure Therapeutics Inc. (GPCR): Officer, COO & GC
- Metsera, Inc. (MTSR): Officer, Chief Legal Officer
- Lyell Immunopharma, Inc. (LYEL): Officer, Chief Business Officer
Lang Matthew
CIK: 0001712069
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (80.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (20.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Apr 15, 2026GPCR
Structure Therapeutics Inc.
AwardDirect184.6K shares- - Nov 13, 2025MTSR
Metsera, Inc.
DispositionDirect12.5K shares- - Nov 13, 2025MTSR
Metsera, Inc.
AwardDirectRestricted Stock Unit
12.5K shares- - May 20, 2025MTSR
Metsera, Inc.
AwardDirectStock Option (Right to Buy)
46.9K shares- - Feb 10, 2025LYEL
Lyell Immunopharma, Inc.
AwardDirect112.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 15, 2026 |  GPCR Structure Therapeutics Inc. | Award | 184,614 | - | $0 | Direct |
| Nov 13, 2025 |  MTSR Metsera, Inc. | Disposition | 12,500 | - | - | Direct |
| Nov 13, 2025 | MTSR Metsera, Inc. | Award Restricted Stock Unit | 12,500 | - | - | Direct |
| May 20, 2025 | MTSR Metsera, Inc. | Award Stock Option (Right to Buy) | 46,875 | - | - | Direct |
| Feb 10, 2025 |  LYEL Lyell Immunopharma, Inc. | Award | 112,500 | - | - | Direct |
1-5 of 5 transactions